Marketing authorization holders for prescription drugs in Australia will have five years to fully transition to new drug labeling standards, but can begin complying with the new rules from Oct. 1, 2026.
Marketing authorization holders for prescription drugs in Australia will have five years to fully transition to new drug labeling standards, but can begin complying with the new rules from Oct. 1, 2026.